Anja J. Rueten‐Budde

Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas

Veroniek M. van Praag, Anja J. Rueten‐Budde, Vincent K.Y. Ho et al. · Surgical Oncology · 2018 · 213 citations · Full text

Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study

M.J.L. Mastboom, Emanuela Palmerini, F.G.M. Verspoor et al. · The Lancet Oncology · 2019 · 124 citations · Full text

Surgical Oncology, Tumoral Pathology, Medicine +9

A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC)

Veroniek M. van Praag, Anja J. Rueten‐Budde, Lee Jeys et al. · European Journal of Cancer · 2017 · 114 citations

Prediction Model, Surgical Oncology, Medicine +6

Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model

Julie J. Willeumier, Anja J. Rueten‐Budde, Lee Jeys et al. · BMJ Open · 2017 · 50 citations · Full text

Dynamic prediction of overall survival for patients with high-grade extremity soft tissue sarcoma

Anja J. Rueten‐Budde, Veroniek M. van Praag, Michiel A. J. van de Sande et al. · Surgical Oncology · 2018 · 48 citations · Full text